Enliven Therapeutics Files 8-K on Shareholder Vote Matters
Ticker: ELVN · Form: 8-K · Filed: Jun 25, 2025 · CIK: 1672619
| Field | Detail |
|---|---|
| Company | Enliven Therapeutics, Inc. (ELVN) |
| Form Type | 8-K |
| Filed Date | Jun 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
Enliven Therapeutics (formerly IMARA) filed an 8-K for a shareholder vote on June 24th.
AI Summary
Enliven Therapeutics, Inc. filed an 8-K on June 25, 2025, reporting on a submission of matters to a vote of security holders that occurred on June 24, 2025. The company, formerly known as IMARA Inc., is incorporated in Delaware and headquartered in Boulder, Colorado.
Why It Matters
This filing indicates that Enliven Therapeutics is engaging in corporate governance activities, specifically seeking shareholder approval for certain matters, which could impact the company's strategic direction or operational decisions.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure regarding a shareholder vote, not indicating any immediate financial distress or significant operational change.
Key Players & Entities
- Enliven Therapeutics, Inc. (company) — Registrant
- IMARA Inc. (company) — Former company name
- June 24, 2025 (date) — Date of earliest event reported
- June 25, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Boulder, Colorado (location) — Principal executive offices
FAQ
What specific matters were submitted for a vote of security holders?
The filing states that the 8-K is for the 'Submission of Matters to a Vote of Security Holders' but does not detail the specific matters in the provided text.
When did the event related to the shareholder vote occur?
The earliest event reported, which is the submission of matters to a vote of security holders, occurred on June 24, 2025.
What is the exact name of the company filing this report?
The exact name of the registrant is Enliven Therapeutics, Inc.
What was the company's former name?
The company's former name was IMARA Inc.
Where are Enliven Therapeutics' principal executive offices located?
Enliven Therapeutics' principal executive offices are located at 6200 Lookout Road, Boulder, Colorado, 80301.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 25, 2025 regarding Enliven Therapeutics, Inc. (ELVN).